Verbal fluency predicts mortality in Alzheimer disease

Cognitive and Behavioral Neurology

Volumn 19, Issue 3, 2006, Pages 123-129

  Cosentino, Stephanie ^a,b   Scarmeas, Nikolaos ^a,b   Albert, Steven M ^a,b   Stern, Yaakov ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Alzheimer disease; Mortality; Neuropsychology; Prognosis; Verbal fluency

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MORTALITY; NEUROPSYCHOLOGICAL TEST; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; VERBAL BEHAVIOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; FRONTAL LOBE; GERIATRIC ASSESSMENT; HUMANS; LANGUAGE DISORDERS; LANGUAGE TESTS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; PHONETICS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; VERBAL BEHAVIOR;

EID: 33748563985     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnn.0000213912.87642.3d     Document Type: Article

References (43)

1. Brookmeyer R, Corrada MM, Curriero FC, et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59:1764-1767.
2. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001;344:1111-1116.
3. Stern Y, Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;277:806-812.
4. Ueki A, Shinjo H, Shimode H, et al. Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study. Int J Geriatr Psychiatry. 2001;16:810-815.
5. Burns A, Lewis G, Jacoby R, et al. Factors affecting survival in Alzheimer's disease. Psychol Med. 1991;21:363-370.
6. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 1994;44:2300-2307.
7. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501-509.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
9. Hui JS, Wilson RS, Bennett DA, et al. Rate of cognitive decline and mortality in Alzheimer's disease. Neurology. 2003;61:1356-1361.
10. Mungas D, Wallace R, Reed B. Dimensions of cognitive ability in dementia: differential sensitivity to degree of impairment in Alzheimer's disease. Clin Neuropsychologist. 1998;12:129-142.
11. Haxby JV, Grady CL, Koss E, et al. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology. 1988;38:1853-1863.
12. Galton CJ, Patterson K, Xuereb JH, et al. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000;123 (Pt 3):484-498.
13. Fisher NJ, Rourke BP, Bieliauskas LA. Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data. J Clin Exp Neuropsychol. 1999;21:488-518.
14. Aharon-Peretz J, Israel O, Goldsher D, et al. Posterior cortical atrophy variants of Alzheimer's disease. Dement Geriatr Cogn Disord. 1999;10:483-487.
15. Johnson JK, Head E, Kim R, et al. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol. 1999;56:1233-1239.
16. Lambon Ralph MA, Patterson K, Graham N, et al. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain. 2003;126(Pt 11):2350-2362.
17. Binetti G, Magni E, Padovani A, et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;60:91-93.
18. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging. 2000;21:845-861.
19. Mann UM, Mohr E, Gearing M, et al. Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry. 1992;55:956-959.
20. Kanne SM, Balota DA, Storandt M, et al. Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurology. 1998;50:979-985.
21. Coen RF, Maguire C, Swanwick GR, et al. Letter and category fluency in Alzheimer's disease: a prognostic indicator of progression? Dementia. 1996;7:246-250.
22. Stern Y, Gurland B, Tatemichi TK, et al. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271:1004-1010.
23. Scarmeas N, Levy G, Tang MX, et al. Influence of leisure activity on the incidence of Alzheimer's disease. Neurology. 2001;57:2236-2242.
24. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
25. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
26. Benton AL. The Visual Retention Test. New York: The Psychological Corp; 1955.
27. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia, PA: Lea & Febiger; 1983.
28. Benton AL, Hamsher K, Sivan AB. Manual for the Multilingual Aphasia Examination. 3rd ed. Iowa City, Iowa: AJA Associates, Inc; 1994.
29. Goodglass H, Kaplan D. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, PA: Lea & Febiger; 1983.
30. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corp; 1981.
31. Mattis S. Mental Status Examination for Organic Mental Syndrome in the Elderly Patient. New York: Grune & Stratton; 1976.
32. Rosen W. The Rosen Drawing Test. Bronx, NY: Veterans Administration Medical Center; 1981.
33. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49:453-460.
34. Association AP. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press, Inc; 1987.
35. Monsch AU, Bondi MW, Butters N, et al. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol. 1992;49:1253-1258.
36. Bracco L, Gallato R, Grigoletto F, et al. Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study. Arch Neurol. 1994;51:1213-1219.
37. Kitabayashi Y, Ueda H, Tsuchida H, et al. Relationship between regional cerebral blood flow and verbal fluency in Alzheimer's disease. Psychiatry Clin Neurosci. 2001;55:459-463.
38. Rosser A, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1994;57:1389-1394.
39. Henry JD, Crawford JR, Phillips LH. Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Neuropsychologia. 2004;42:1212-1222.
40. Keilp JG, Gorlyn M, Alexander GE, et al. Cerbral blood flow patterns underlying the differential impairment in category vs letter fluency in Alzheimer's disease. Neuropsychologia. 1999;37:1251-1261.
41. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65:719-725.
42. Chan D, Fox NC, Jenkins R, et al. Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology. 2001;57:1756-1763.
43. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143-1153.